FAYEZ SAROFIM & CO – Abbott Laboratories Transaction History
FAYEZ SAROFIM & CO portfolio value:
$439.46M
portfolio value
FAYEZ SAROFIM & CO quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.36% | -16.52K shares | -55.79M | $96.76 | 4.54M |
| Q2 2022 | share | Decrease | -0.44% | -20.33K shares | -46.66M | $108.65 | 4.55M |
| Q1 2022 | share | Decrease | -3.33% | -157.86K shares | -124.68M | $118.36 | 4.57M |
| Q4 2021 | share | Decrease | -0.57% | -26.94K shares | 103.91M | $141 | 4.73M |
| Q3 2021 | share | Increase | +4.71% | 214.41K shares | 35.33M | $117.68 | 4.76M |
| Q2 2021 | share | Increase | +0.32% | 14.59K shares | -16.03M | $115.05 | 4.54M |
| Q1 2021 | share | Increase | +0.16% | 7.18K shares | 47.71M | $118.49 | 4.53M |
| Q4 2020 | share | Increase | +0.80% | 35.83K shares | 6.88M | $107.81 | 4.52M |
| Q3 2020 | share | Increase | +3.32% | 144.19K shares | 91.33M | $106.81 | 4.49M |
| Q2 2020 | share | Increase | +18.08% | 665.57K shares | 106.95M | $89.39 | 4.34M |
| Q1 2020 | share | Increase | +0.24% | 8.64K shares | -28.52M | $76.84 | 3.68M |
| Q4 2019 | share | Decrease | -2.39% | -89.95K shares | 4.19M | $84.23 | 3.67M |
| Q3 2019 | share | Increase | +1.18% | 43.77K shares | 2.06M | $80.81 | 3.76M |
| Q2 2019 | share | Decrease | -2.28% | -86.74K shares | 8.53M | $80.92 | 3.71M |
| Q1 2019 | share | Increase | +0.29% | 10.97K shares | 29.75M | $76.6 | 3.80M |
| Q4 2018 | share | Decrease | -1.88% | -72.83K shares | -9.27M | $68.98 | 3.79M |
| Q3 2018 | share | Decrease | -1.38% | -54.18K shares | 44.56M | $69.69 | 3.86M |
| Q2 2018 | share | Decrease | -2.17% | -86.99K shares | -1.01M | $57.68 | 3.92M |
| Q1 2018 | share | Decrease | -1.17% | -47.63K shares | 8.70M | $56.4 | 4.00M |
| Q4 2017 | share | Decrease | -6.00% | -258.89K shares | 1.23M | $53.46 | 4.05M |
| Q3 2017 | share | Decrease | -1.45% | -63.52K shares | 17.41M | $49.74 | 4.31M |
| Q2 2017 | share | Decrease | -2.91% | -131.29K shares | 12.56M | $45.07 | 4.37M |
| Q1 2017 | share | Decrease | -7.52% | -366.81K shares | 12.97M | $40.93 | 4.51M |
| Q4 2016 | share | Decrease | -4.94% | -253.39K shares | -29.75M | $35.17 | 4.87M |
| Q3 2016 | share | Decrease | -2.57% | -135.18K shares | 9.98M | $38.48 | 5.13M |
| Q2 2016 | share | Decrease | -0.32% | -16.89K shares | -14.04M | $35.55 | 5.26M |
| Q1 2016 | share | Decrease | -1.23% | -65.80K shares | -17.96M | $37.6 | 5.28M |